← All stocks

Fulgent Genetics, Inc.

FLGT Net selling
CIK 0001674930 #3026 in the set updated 17 Sep 2026
Bought (120 mo)
$11.16M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$31.16M
$0.00 on a plan · $1.22M straight out of an exercise
Sold at will
$29.94M
145 of 159 sales
Net
−$20.01M
−$18.79M against sales at will

By person

13 insiders · 179 transactions
52.0×

Ming Hsieh holds 52.0 times base salary in stock. $52.02M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Ming Hsieh last reported holding, valued at $19.66, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Kim Paul
CFO and Treasurer
$1.60M (1)
$18.39M (57)
−$16.80M
356,543
$7.01M
−88.1%
Xie Jian
President and COO
$10.77M (55)
−$10.77M
801,556
$15.76M
+30.4%
Hsieh Ming
Chief Executive Officer
$9.56M (19)
$93.48K (2)
+$9.47M
2,646,373
$52.02M
BOLGER JOHN C
Director
$1.23M (15) scheduled
−$1.23M
5,100
$100.25K
+155.0%
Gao Hanlin
Chief Scientific Officer
$680.30K (30)
−$680.30K
986,117
$19.38M
−92.7%
Xi Long USA, Inc. entity
10% owner
2,025,623
$39.82M
Dong Linda
Director
38,758
$761.84K
GROVES REGINA E
Director
28,099
$552.33K
Nohaile Michael
Director
24,578
$483.11K
POST LEONARD E
Director
8,000
$157.25K
Mulay James
Director
8,000
$157.25K
Fulgent Genetics, Inc. entity
Director
6,842
$134.49K
+140.7%
Yen Yun
Director
2,000
$39.31K
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Kim Paul
5 Mar 2025
CFO and Treasurer
Buy
100,000
$15.96
$1.60M
Hsieh Ming
5 Mar 2019
President and CEO
Buy
8,739
$4.95
$43.24K
Hsieh Ming
13 Nov 2018
President and CEO
Buy
10,880
$3.59
$39.03K
Hsieh Ming
9 Nov 2018
President and CEO
Buy
10,000
$3.36
$33.61K
Hsieh Ming
30 Nov 2017
President and CEO
Buy indirect
1,000
$3.60
$3.60K
Hsieh Ming
30 Nov 2017
President and CEO
Buy indirect
1,000
$3.60
$3.60K
Hsieh Ming
21 Nov 2017
President and CEO
Buy
1,599
$3.13
$5.00K
Hsieh Ming
20 Nov 2017
President and CEO
Buy
7,259
$3.28
$23.81K
Hsieh Ming
17 Nov 2017
President and CEO
Buy
12,291
$3.16
$38.86K
Hsieh Ming
16 Nov 2017
President and CEO
Buy
1,905
$3.22
$6.14K
Hsieh Ming
15 Nov 2017
President and CEO
Buy
300
$3.28
$984.99
Hsieh Ming
14 Nov 2017
President and CEO
Buy
2,800
$3.35
$9.37K
Hsieh Ming
13 Nov 2017
President and CEO
Buy
7,704
$3.28
$25.27K
Hsieh Ming
10 Nov 2017
President and CEO
Buy
9,385
$3.35
$31.40K
Hsieh Ming
9 Nov 2017
President and CEO
Buy
11,520
$3.47
$40.03K
Hsieh Ming
15 Jun 2017
President and CEO
Buy
12,700
$5.35
$67.95K
Hsieh Ming
14 Jun 2017
President and CEO
Buy
7,300
$5.11
$37.28K
Hsieh Ming
13 Jun 2017
President and CEO
Buy
15,000
$5.01
$75.19K
Hsieh Ming
12 Jun 2017
President and CEO
Buy
15,000
$4.95
$74.21K
Hsieh Ming
30 Sep 2016
President and CEO
Buy
1,000,000
$9.00
$9.00M

What was left out

Form 4 filings counted 381
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 145
Transactions with no price 0
Shares from compensation/vesting 37,252,986
Sales filed before the plan box existed 84
History held since 4 Oct 2016